Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

KB Home Gets Price Target Bumps By Analysts Following Better-Than-Expected Q1 Results

KB Home (NYSE: KBH) reported better-than-expected Q1 results. The company posted quarterly revenue of $1.38 billion, beating estimates of $1.31 billion. Earnings came in at $1.45 per share, topping expectations of $1.14 per share.
byLisa Levin
March 24, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

KB Home (NYSE:KBH) reported better-than-expected Q1 results.

The company posted quarterly revenue of $1.38 billion, beating estimates of $1.31 billion. Earnings came in at $1.45 per share, topping expectations of $1.14 per share.

KB Home shares jumped 7.5% to close at $39.57 on Thursday.

These analysts made changes to their price targets on KB Home following the release of results.

  • Barclays raised the price target on KB Home from $42 to $51. Barclays analyst Matthew Bouley maintained an Overweight rating.
  • JP Morgan increased the price target on KB Home from $32.5 to $42.5. JP Morgan analyst Michael Rehaut upgraded the stock from Underweight to Neutral.

Check This Out: Why Fear Level Among US Investors Is Increasing

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Zai Lab To Present Analysis Of The Impact Of Timing For ZEJULA Maintenance Treatment In Newly Diagnosed Advanced Ovarian Cancer At The 2022 International Gynecologic Cancer Society Meeting September 29 – October 1, 2022

By Benzinga Newsdesk
September 20, 8:09 AM
SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB, HKEX: 9688)))), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, will

ZLAB